# Whole Genome Sequencing in Breast Cancer

> **NCT06334471** · — · RECRUITING · sponsor: **Inocras Korea Inc.** · enrollment: 1200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** no intervention needed

## Key facts

- **NCT ID:** NCT06334471
- **Lead sponsor:** Inocras Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-02
- **Primary completion:** 2025-08-02
- **Final completion:** 2030-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334471, "Whole Genome Sequencing in Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06334471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*